Suppr超能文献

带血管腓骨移植治疗股骨头骨骺滑脱后缺血性坏死:髋关节能否保留?

Vascularized fibular grafts for avascular necrosis after slipped capital femoral epiphysis: is hip preservation possible?

机构信息

Department of Orthopaedics, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Clin Orthop Relat Res. 2013 Jul;471(7):2206-11. doi: 10.1007/s11999-012-2781-x. Epub 2013 Jan 16.

Abstract

BACKGROUND

Avascular necrosis (AVN) of the femoral head is a potential complication in patients with slipped capital femoral epiphysis (SCFE), radiographically occurring in 3-60%. This may lead to early hip fusion or hip arthroplasty. Free vascularized fibular grafting (FVFG) may provide a reasonable means to preserve the femoral head.

QUESTIONS/PURPOSES: We asked: (1) What percentage of patients with AVN after SCFE treated with FVFG underwent subsequent THA or hip fusion and what was the lifespan of the FVFG? (2) Did the graft survival rate of FVFG for AVN after SCFE coincide with historically reported rates of FVFG for idiopathic AVN? And (3) did hip function improve after FVFG?

METHODS

We retrospectively reviewed 52 patients who underwent FVFG for SCFE. We calculated the longevity of the graft and factors associated with graft survival. Harris hip scores (HHS) were recorded pre- and postoperatively. Minimum followup was 1 month (median, 19 months; range, 1-136 months).

RESULTS

Five of the 52 patients (10%) underwent conversion to THA (four) or hip fusion (one). Mean age was greater in these patients than in those not requiring further procedures: 16 versus 13 years. Median graft survival time before arthroplasty/fusion was 12 years (range, 2-16 years) while it is currently 8 years (range, 2-16 years) in patients not undergoing subsequent procedures. HHSs improved 35 points on average (38 points preoperatively to 73 points postoperatively).

CONCLUSIONS

In patients undergoing FVFG for AVN secondary to SCFE, 90% have maintained their native hips for 8 years with improved hip function, similar to other published reports of FVFG. Further followup is needed of patients currently retaining their FVFGs as to eventual conversion to THA or fusion.

LEVEL OF EVIDENCE

Level IV, therapeutic study. See Instructions for Authors for a complete description of levels of evidence.

摘要

背景

股骨头缺血性坏死(AVN)是骺滑脱(SCFE)患者的潜在并发症,放射学发生率为 3-60%。这可能导致早期髋关节融合或髋关节置换。游离血管化腓骨移植(FVFG)可能是保留股骨头的合理手段。

问题/目的:我们提出了以下问题:(1)接受 FVFG 治疗的 SCFE 后发生 AVN 的患者中有多少例随后接受了 THA 或髋关节融合,FVFG 的寿命是多少?(2)FVFG 治疗 SCFE 后 AVN 的移植物存活率是否与 FVFG 治疗特发性 AVN 的历史报告率相符?(3)FVFG 后髋关节功能是否改善?

方法

我们回顾性分析了 52 例接受 FVFG 治疗的 SCFE 患者。我们计算了移植物的寿命和与移植物存活相关的因素。记录术前和术后的 Harris 髋关节评分(HHS)。随访时间至少为 1 个月(中位数 19 个月;范围 1-136 个月)。

结果

52 例患者中有 5 例(10%)需要进行关节置换(4 例)或髋关节融合(1 例)。需要进一步手术的患者年龄大于不需要进一步手术的患者:16 岁对 13 岁。在需要进行关节置换/融合之前,移植物的中位存活时间为 12 年(范围 2-16 年),而目前未进行进一步手术的患者的移植物存活时间为 8 年(范围 2-16 年)。HHS 平均提高了 35 分(术前 38 分,术后 73 分)。

结论

在接受 FVFG 治疗 SCFE 继发 AVN 的患者中,90%的患者在 8 年内保持了自己的髋关节,髋关节功能得到了改善,这与其他发表的 FVFG 报告相似。需要进一步随访目前保留 FVFG 的患者,以了解他们最终是否需要进行 THA 或融合。

证据水平

IV 级,治疗性研究。请参阅作者说明,以获取完整的证据水平描述。

相似文献

引用本文的文献

1
Follow-up After Proximal Femur Fracture Fixation-We Need to Do Better.股骨近端骨折固定后的随访——我们需要做得更好。
J Pediatr Soc North Am. 2025 Jun 21;12:100231. doi: 10.1016/j.jposna.2025.100231. eCollection 2025 Aug.
7
Free vascularised fibular grafts in orthopaedics.骨科游离腓骨移植。
Int Orthop. 2014 Jun;38(6):1277-82. doi: 10.1007/s00264-014-2281-6. Epub 2014 Feb 22.

本文引用的文献

5
Nontraumatic osteonecrosis of the femoral head: ten years later.非创伤性股骨头坏死:十年之后
J Bone Joint Surg Am. 2006 May;88(5):1117-32. doi: 10.2106/JBJS.E.01041.
6
Pediatric femoral avascular necrosis after pyarthrosis: use of free vascularized fibular grafting.
Clin Orthop Relat Res. 2005 Oct;439:193-200. doi: 10.1097/01.blo.0000176149.16509.e5.
9
Treatment of osteonecrosis with autologous bone marrow grafting.自体骨髓移植治疗骨坏死。
Clin Orthop Relat Res. 2002 Dec(405):14-23. doi: 10.1097/00003086-200212000-00003.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验